HEPACAM and multiple sclerosis: The recent findings on the EBV EBNA1-derived peptide inducing multiple sclerosis (MS) through the mimicry of GlialCAM further suggest that EBV tropism did not limit its capability of causing cytopathy in remote uninfected cells [87].